Efficiency of Combined Treatment of Barrett's Esophagus and Erosive Esophagitis by Proton Pump Inhibitors and Ursodeoxycholic Acid

Trial Profile

Efficiency of Combined Treatment of Barrett's Esophagus and Erosive Esophagitis by Proton Pump Inhibitors and Ursodeoxycholic Acid

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Nov 2011

At a glance

  • Drugs Ursodeoxycholic acid (Primary) ; Omeprazole
  • Indications Barrett's oesophagus; Erosive oesophagitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Nov 2011 New trial record
    • 26 Oct 2011 Results presented at the 19th United European Gastroenterology Week.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top